Teresa Brophy Bair serves as Executive at Kura Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Teresa Brophy Bair has executed 11 insider transactions totaling $303.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 100,000 shares valued at $0.
Teresa Brophy Bair currently holds 100,000 shares of Kura Oncology, Inc. (KURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Teresa Brophy Bair has been a net seller of KURA stock. They have purchased $0 and sold $303.6K worth of shares.
Teresa Brophy Bair's most recent insider trade was on Jan 2, 2026, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 14, 2025 | KURA | $98.4K | Sale | 8,804 | $11.18 | Discretionary |
| Nov 13, 2025 | KURA | $0 | Award | 48,900 | $N/A | Discretionary |
| Sep 29, 2025 | KURA | $78.7K | Sale | 8,805 | $8.94 | Discretionary |
| Sep 27, 2025 | KURA | $0 | Award | 48,900 | $N/A | Discretionary |
| May 20, 2024 | KURA | $57.9K | Sale | 2,615 | $22.15 | Planned |
| Jan 29, 2024 | KURA | $36.5K | Sale | 2,053 | $17.80 | Discretionary |
| Jan 2, 2024 | KURA | $0 | Award | 46,250 | $N/A | Discretionary |
| Feb 16, 2023 | KURA | $0 | Award | 23,125 | $N/A | Discretionary |
| Nov 17, 2022 | KURA | $32.0K | Sale | 2,100 | $15.22 | Discretionary |